sch 34826 has been researched along with beta-funaltrexamine in 1 studies
| Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (beta-funaltrexamine) | Trials (beta-funaltrexamine) | Recent Studies (post-2010) (beta-funaltrexamine) |
|---|---|---|---|---|---|
| 31 | 2 | 0 | 542 | 1 | 54 |
| Protein | Taxonomy | sch 34826 (IC50) | beta-funaltrexamine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.082 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.082 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Innes, DG; Kavaliers, M | 1 |
1 other study(ies) available for sch 34826 and beta-funaltrexamine
| Article | Year |
|---|---|
Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
Topics: Analgesia; Analgesics; Animals; Dioxolanes; Dipeptides; Enkephalin, Leucine; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Peromyscus; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Restraint, Physical; Sex Characteristics; Stress, Psychological | 1993 |